- Intranasal booster using an Omicron vaccine confers broad mucosal and systemic immunity against SARS-CoV-2 variants (vol 8, 167, 2023)Wang, Qian; Yang, Chenchen; Yin, Li; Sun, Jing; Wang, Wei; Li, Hengchun; Zhang, Zhengyuan; Chen, Si; Liu, Bo; Liu, Zijian; Shi, Linjing; Liu, Xiaolin; Guan, Suhua; Wang, Chunhua; Qu, Linbing; Feng, Ying; Niu, Xuefeng; Feng, Liqiang; Zhao, Jincun; Li, Pingchao; Chen, Ling; Zhong, NanshanSignal Transduction and Targeted Therapy, 2023, 8(1): 215.
- CLINICAL CHARACTERISTICS OF PATIENTS WITH SARSCOV-2 OMICRON VARIANT AND COVID-19 VACCINATION WITH CLINICAL OUTCOME FINDINGS IN SHANGHAI, CHINA: A SINGLE CENTER, RETROSPECTIVE, OBSERVATIONAL STUDYYang, D.; Li, J.; Weng, H.; Lu, X.; Yang, W.; Qiang, J.; Chen, Z.; V, H.; Xuan, J.
- Neutralization of Omicron XBB.1 by booster vaccination with BA.4/5 monovalent mRNA vaccineZhao, Hui; Zhang, Na-Na; Hannawi, Suad; Zhu, Ai-Ru; Xiong, Xiao-Chuan; Huang, Yi-Jiao; Yu, Dan-Dan; Chen, Can-Jie; Dai, Jun; Abuquta, Alaa; Ying, Bo*; Zhao, Jin-Cun*; Qin, Cheng-Feng*Cell Discovery, 2024, 10(1): 7.
期刊论文
Does the homologous booster with the inactivated coronavirus disease 2019 vaccine work for the omicron variant? Real-world evidence from Jilin, China
5阅读
